SCHEMBL29702802

SCHEMBL29702802

Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)C=Cc2ccccc2)C1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 20/20 0.84
EGFR P00533 7/20 0.81
TEC P42680 3/20 0.81
BMX P51813 3/20 0.81
ITK Q08881 3/20 0.81
TXK P42681 2/20 0.81
LYN P07948 2/20 0.81
FGFR2 P21802 2/20 0.81
LCK P06239 2/20 0.81
JAK3 P52333 2/20 0.81
BLK P51451 2/20 0.81
RIPK2 O43353 1/20 0.81
NR1I2 O75469 1/20 0.81
SLC22A3 O75751 1/20 0.81
LATS1 O95835 1/20 0.81
NUDT14 O95848 1/20 0.81
ABL1 P00519 1/20 0.81
ERBB2 P04626 1/20 0.81
FYN P06241 1/20 0.81
PGR P06401 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28744512 1.00 BTK (0.84) BTKEGFRTECBMXITK
SCHEMBL29702894 0.95 BTK (0.80) BTKEGFRTECBMXITK
SCHEMBL28744519 0.95 BTK (0.80) BTKEGFRTECBMXITK
SCHEMBL29702952 0.95 BTK (0.78) BTKEGFRTECBMXITK
SCHEMBL28744493 0.95 BTK (0.81) BTKEGFRTECBMXITK
SCHEMBL29702947 0.95 BTK (0.81) BTKEGFRTECBMXITK
SCHEMBL28744505 0.95 BTK (0.78) BTKEGFRTECBMXITK
SCHEMBL28941050 0.93 BTK (0.78) BTKEGFRTECBMXITK
SCHEMBL29702817 0.93 BTK (0.78) BTKEGFRTECBMXITK
SCHEMBL28744913 0.93 BTK (0.75) BTKEGFRTECBMXITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114605418-B Ibrutinib acrylamide derivative with anti-tumor activity, and synthetic method and application thereof 广东医科大学附属医院 2023-09-05 CN disclosed
CN-114605418-A Ibrutinib acrylamide derivative with antitumor activity and synthesis method and application thereof 广东医科大学附属医院 2022-06-10 CN disclosed